Advances and Future Directions in the Targeting of HER2-positive Breast Cancer: Implications for the Future

Author： Subbiah Ishwaria   Gonzalez-Angulo Ana  

Publisher： Springer Publishing Company

ISSN： 1527-2729

Source： Current Treatment Options in Oncology, Vol.15, Iss.1, 2014-03, pp. : 41-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Future Directions in the Treatment of Metastatic Breast Cancer

By Zwierzina H.   Gnant M.   Krainer M.   Wiltschke Ch.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 117-118

Springer Publishing Company

Access to resources Recommend Favorite

Treatment strategy for HER2-positive breast cancer

By Mukai Hirofumi  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 335-340

Springer Publishing Company

Access to resources Recommend Favorite

Future directions in the adjuvant treatment of breast cancer: The role of trastuzumab

By Smith I.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 75-79

Springer Publishing Company

Access to resources Recommend Favorite

Future Directions in the Treatment of Breast Cancer – Cellular Interventions Using Dendritic Cells

By Gnant Michael F.X.   Dubsky Peter C.   Stift Anton   Friedl Josef   Steger Guenther G.   Jakesz Raimund   Zielinski Christoph C.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 119-123

Springer Publishing Company

Access to resources Recommend Favorite

Proposed treatment guidelines for HER2-positive metastatic breast cancer in Europe

By Piccart M.J.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 89-94

Springer Publishing Company

Access to resources Recommend Favorite